Clinical trial
Effectiveness Of Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients (A Randomized, Controlled Clinical Trial)
NCT06703372 is registered in ClinicalTrials.gov with Hams Hamed Abdelrahman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness Of Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients (A Randomized, Controlled Clinical Trial)
- Lead sponsor
- Hams Hamed Abdelrahman
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 20, 2022
- Completion date
- August 1, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.